XOMA Royalty's revenue per share for the
three
months ended in Sep. 2024 was $0.06.
XOMA Royalty's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.68.
Warning Sign:
XOMA Royalty Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of XOMA Royalty was 76.10% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -45.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -15.90% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -20.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for XOMA Royalty's Revenue per Share or its related term are showing as below:
LTS:0M26'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -73.1 Med: -18.9 Max: 284.2
Current: -45.4
During the past 13 years, XOMA Royalty's highest 3-Year average Revenue Per Share Growth Rate was 284.20% per year. The lowest was -73.10% per year. And the median was -18.90% per year.
LTS:0M26's 3-Year Revenue Growth Rate is ranked worse than 89.72% of 759
companies
in the Biotechnology industry
Industry Median: 3.5
vs LTS:0M26: -45.40
XOMA Royalty Revenue per Share Historical Data
The historical data trend for XOMA Royalty's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of XOMA Royalty's Revenue per Share
For the Biotechnology subindustry, XOMA Royalty's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XOMA Royalty's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XOMA Royalty's PS Ratio distribution charts can be found below:
* The bar in red indicates where XOMA Royalty's PS Ratio falls into.
XOMA Royalty Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
XOMA Royalty's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XOMA Royalty (LTS:0M26) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
XOMA Royalty Revenue per Share Related Terms
Thank you for viewing the detailed overview of XOMA Royalty's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0M26 has been successfully added to your 